Delivery Order SPE2DB22D3501-SPE2DB25FUR01
Award Date
2/21/25
Potential Completion Date
2/24/25
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,210.56, is for the supply of Budesonide-Formoterol 80-4.5 10.2GM, a respiratory medication, with a final delivery date of December 12, 2023. The contract is structured as a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen also holds a larger Indefinite...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Budesonide-Formoterol 160-4.5 10.2GM medication. The contract has a Firm Fixed Price pricing type, a ceiling value of $1,515.72, and an ultimate completion date of October 11, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,455.63, is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of January 31, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,566,747,323 units of the drug Budesonide-Formoterol 160-4.5 10.2GM, with a ceiling value of $1,696.32 and a period of performance through December 18, 2024. This contract is not designated as a set-aside and is a firm-fixed-price delivery order under a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Budesonide-Formoterol 160-4.5 10.2GM medication. The contract has a ceiling value of $5,779.02 and an ultimate completion date of September 10, 2024. It is a firm fixed-price contract with no set-aside designation. AmerisourceBergen, through its extensive supply chain network, will provide this critical pharmaceutical product...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,982.68, is for the delivery of budesonide-formoterol 80-4.5 10.2 gram medication. The contract has a completion date of February 10, 2025 and is a firm fixed price delivery order. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Budesonide-Formoterol 80-4.5 10.2GM, a medical commodity. The contract has a firm fixed price of $2,118.84 and a completion date of October 31, 2024. While the original solicitation is not provided, the contract appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, and has a total ceiling value of $16,773.40. The contract is a firm fixed-price delivery order with a performance period ending on February 5, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for budesonide-formoterol 160-4.5 10.2GM, a pharmaceutical product, with a ceiling value of $3,039.77 and a completion date of January 8, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, with a ceiling value of $1,329.35. The contract is a firm fixed-price delivery order, with an ultimate completion date of October 10, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds several Indefinite...